News

Pipeline Therapeutics Completes $80 Million Series C Financing

Turnstone Biologics Acquires Novel Cell Therapy Platform

GrubMarket raises $60M as food delivery stays center stage

GrubMarket Raised $90 Million in 2020

Turnstone Biologics Announces First Patients in Phase 1/2 Clinical Trial for RIVAL-01

Libra Launches with $29M Series A to Develop Novel Therapeutics for Neurodegenerative Diseases

Antios Therapeutics Completes Phase 1b Trial for Hepatitis B Virus

Antios Therapeutics Appoints Gregory T. Mayes Chief Executive Officer

Veem Secures $31M in Strategic Funding Round

Connect Easier. Move Faster. Live Longer.

Sixty Degree Capital Inc. © 2020